EFG Asset Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$4.88M Buy
36,507
+4,221
+13% +$513K 0.63% 58
2025
Q2
$4.02M Buy
32,286
+19,363
+150% +$2.46M 0.57% 74
2025
Q1
$1.65M Sell
12,923
-6,374
-33% -$981K 0.27% 151
2024
Q4
$2.78M Sell
19,297
-3,026
-14% -$434K 0.38% 110
2024
Q3
$3.32M Sell
22,323
-2,501
-10% -$359K 0.56% 51
2024
Q2
$3.13M Buy
24,824
+4,765
+24% +$747K 0.54% 57
2024
Q1
$3.69M Buy
20,059
+4,309
+27% +$821K 0.64% 45
2023
Q4
$2.83M Sell
15,750
-702
-4% -$109K 0.54% 70
2023
Q3
$2.61M Buy
16,452
+4,890
+42% +$799K 0.62% 58
2023
Q2
$1.63M Buy
+11,562
New +$1.85M 0.35% 97

Other funds holding RGEN

EFG Asset Management's RGEN Position: Q3 2025 in Review

EFG Asset Management increased its Repligen (RGEN) stake by 13% in Q3 2025, buying an estimated $513K and bringing the position to 36,507 shares worth $4.88M. The position accounts for 0.63% of the portfolio, ranked #58.

EFG Asset Management first reported a position in RGEN in Q2 2023 and has held it in 10 quarters since. 451 funds tracked by Wall St. Rank hold RGEN as of Q3 2025.

  • EFG Asset Management held 36,507 shares of Repligen worth $4.88M as of Q3 2025.
  • EFG Asset Management bought 4,221 Repligen shares in Q3 2025, an estimated $513K.
  • Repligen made up 0.63% of EFG Asset Management's portfolio in Q3 2025, its #58 holding.
  • EFG Asset Management first reported a position in Repligen in Q2 2023 and has held it in 10 quarters since.
  • 451 funds tracked by Wall St. Rank held Repligen as of Q3 2025.

Based on EFG Asset Management's 13F filing for Q3 2025, filed 3 Nov 2025.